{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:43:34Z","timestamp":1793943814333,"version":"4.8.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofpsychiatricresearch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jpsychires.2017.02.020","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T18:45:19Z","timestamp":1488221119000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"special_numbering":"C","title":["Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study"],"prefix":"10.1016","volume":"91","author":[{"given":"Markus","family":"Dold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Bartova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Souery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Mendlewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Serretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Porcelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Zohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2017.02.020_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology","volume":"28","author":"Baldwin","year":"2014","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2017.02.020_bib2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jad.2015.09.033","article-title":"Socio-demographic and clinical predictors of treatment resistant depression: a prospective European multicenter study","volume":"189","author":"Balestri","year":"2016","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.jpsychires.2017.02.020_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/15622970802465807","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision","volume":"9","author":"Bandelow","year":"2008","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.020_bib4","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1176\/ajp.148.11.1512","article-title":"Follow-up and family study of anxious depression","volume":"148","author":"Clayton","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.020_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13651501.2016.1248852","article-title":"Evidence-based pharmacotherapy of treatment-resistant unipolar depression","volume":"21","author":"Dold","year":"2017","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.jpsychires.2017.02.020_bib6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1017\/S0033291704002612","article-title":"Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D","volume":"34","author":"Fava","year":"2004","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2017.02.020_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ajp.2007.06111868","article-title":"Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report","volume":"165","author":"Fava","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.020_bib8","first-page":"107","article-title":"Anxious depression in elderly patients. Response to antidepressant treatment","volume":"5","author":"Flint","year":"1997","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.020_bib9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/da.21939","article-title":"The importance of anxiety in both major depression and bipolar disorder","volume":"29","author":"Goldberg","year":"2012","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2017.02.020_bib10","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1017\/S0033291713001827","article-title":"Anxious and non-anxious forms of major depression: familial, personality and symptom characteristics","volume":"44","author":"Goldberg","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2017.02.020_bib11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1520-6394(1996)4:4<160::AID-DA2>3.0.CO;2-J","article-title":"Comorbid depression and anxiety spectrum disorders","volume":"4","author":"Gorman","year":"1996","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2017.02.020_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A\u00a0rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.020_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00406-014-0523-7","article-title":"Pharmacotherapy of anxiety disorders in German-speaking countries: current status and changes between 1994 and 2011","volume":"265","author":"Holl","year":"2015","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2017.02.020_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.drugalcdep.2008.08.010","article-title":"Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome","volume":"99","author":"Howland","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jpsychires.2017.02.020_bib15","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1176\/ajp.150.8.1257","article-title":"Anxious and nonanxious depression","volume":"150","author":"Joffe","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.020_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/YIC.0b013e32831d7980","article-title":"Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial","volume":"24","author":"Kasper","year":"2009","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2017.02.020_bib17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1017\/S1461145713001557","article-title":"Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder","volume":"17","author":"Kasper","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2017.02.020_bib18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.020_bib19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S1461145711000745","article-title":"Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP international pharmacovigilance program","volume":"15","author":"Konstantinidis","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2017.02.020_bib20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00406-016-0684-7","article-title":"The relevance of 'mixed anxiety and depression' as a diagnostic category in clinical practice","volume":"266","author":"Moller","year":"2016","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2017.02.020_bib21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A\u00a0new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.020_bib22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4088\/JCP.v67n0511","article-title":"Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine","volume":"67","author":"Montgomery","year":"2006","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.020_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.euroneuro.2012.02.006","article-title":"European Group for the Study of Resistant Depression (GSRD) - where have we gone so far: review of clinical and genetic findings","volume":"22","author":"Schosser","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2017.02.020_bib24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.euroneuro.2009.11.011","article-title":"Outcomes of 1014 naturalistically treated inpatients with major depressive episode","volume":"20","author":"Seemuller","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"Suppl.\u00a020","key":"10.1016\/j.jpsychires.2017.02.020_bib25","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.020_bib26","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4088\/JCP.v68n0713","article-title":"Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study","volume":"68","author":"Souery","year":"2007","journal-title":"J.\u00a0Clin. Psychiatry"},{"issue":"Suppl.\u00a06","key":"10.1016\/j.jpsychires.2017.02.020_bib27","first-page":"16","article-title":"Treatment-resistant depression","volume":"67","author":"Souery","year":"2006","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.020_bib28","first-page":"50","article-title":"Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features","volume":"55","author":"Tollefson","year":"1994","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.020_bib29","first-page":"67","article-title":"Anxious depressions. Clinical, family history, and naturalistic outcome\u2013comparisons with panic and major depressive disorders","volume":"6","author":"VanValkenburg","year":"1984","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.jpsychires.2017.02.020_bib30","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4088\/JCP.09m05650blu","article-title":"Prevalence and treatment outcome in anxious versus nonanxious depression: results from the german algorithm project","volume":"71","author":"Wiethoff","year":"2010","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.020_bib31","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","article-title":"The size and burden of mental disorders and other disorders of the brain in Europe 2010","volume":"21","author":"Wittchen","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2017.02.020_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.9758\/cpn.2015.13.3.263","article-title":"Risk factors for anxiety in major depressive disorder patients","volume":"13","author":"Xin","year":"2015","journal-title":"Clin. Psychopharmacol. Neurosci."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395616306689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395616306689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T20:56:43Z","timestamp":1536008203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395616306689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":32,"alternative-id":["S0022395616306689"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2017.02.020","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2017.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}